Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06896578

Latitude - Lateral Lymph Node Attitude Study

Lateral Lymph Nodes in Rectal Cancer Attitude Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Sahlgrenska University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with advanced rectal cancer can sometimes have suspected tumour affected lymph nodes outside the standard operating field. These patients often receive preoperative treatment before surgery. There is a lack of consensus on what to do if there is remaining suspicion of tumour affected lymph nodes after the preoperative treatment. Removal of the lymph nodes using a broader surgical field with dissection of the lateral side-wall is often suggested, but the oncologic outcome is uncertain, and so is the patient reported outcome in terms of side effects. This study aims to study the surgical treatment of tumour affected lateral lymph nodes to understand what lymph nodes require removal, and what effect that will have on oncologic outcome and the patient's function and QoL.

Detailed description

Patients with advanced rectal cancer will receive standard care, if lateral lymph nodes exist after neoadjuvant treatment they will be operated accordingly. The focus will be to compare two groups (with and without lateral lymph node clearance) regarding function, QoL and oncologic outcome. We will also aim to identify features on MRI to improve diagnostic ability.

Conditions

Interventions

TypeNameDescription
PROCEDURELateral lymph node dissectionRemoval of lateral lymph nodes in the obturator and internal iliac compartment including fatty tissue, but excluding vascular and nervous tissue

Timeline

Start date
2025-09-15
Primary completion
2029-02-01
Completion
2034-02-01
First posted
2025-03-26
Last updated
2025-08-08

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06896578. Inclusion in this directory is not an endorsement.